Anne-Laurie Pinto Selected Research

Immune Checkpoint Inhibitors

11/2019

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne-Laurie Pinto Research Topics

Disease

6	Encephalitis (Encephalitis, Rasmussen) 12/2023 - 11/2019
5	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023 - 10/2020
4	Glioma (Gliomas) 01/2022 - 10/2020
3	Neoplasms (Cancer) 12/2023 - 11/2019
2	Autoimmune Diseases of the Nervous System 05/2024 - 01/2021
2	Leukocytosis (Pleocytosis) 05/2024 - 10/2021
2	Cerebellar Diseases (Cerebellar Syndrome) 12/2023 - 12/2020
2	Cerebellar Ataxia (Dysmetria) 01/2022 - 10/2020
2	Ataxia (Dyssynergia) 01/2022 - 01/2021
2	Nervous System Paraneoplastic Syndromes 01/2020 - 11/2019
1	Paraneoplastic Cerebellar Degeneration 12/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023
1	Autoimmune limbic encephalitis 01/2023
1	Inflammation (Inflammations) 01/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Teratoma (Teratoid Tumor) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 12/2020
1	Myasthenia Gravis 10/2020
1	Thymoma (Thymic Carcinoma) 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Isaacs Syndrome (Neuromyotonia) 10/2020
1	Mesothelioma 11/2019

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 05/2024 - 01/2020
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2020
4	Leucine (L-Leucine)FDA Link 01/2022 - 10/2020
2	Immunoglobulin G (IgG)IBA 12/2023 - 12/2020
1	gamma-Aminobutyric Acid (GABA)IBA 05/2024
1	AntigensIBA 12/2023
1	AutoantibodiesIBA 12/2023
1	InterferonsIBA 12/2023
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	adenylate kinase 5IBA 10/2021
1	Oligoclonal BandsIBA 10/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	HLA-DRB1*07 antigenIBA 01/2021
1	N 30IBA 12/2020
1	metabotropic glutamate receptor type 1IBA 12/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2020
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 10/2020
1	Netrin-1IBA 10/2020
1	pembrolizumabIBA 11/2019
1	NivolumabIBA 11/2019
1	Immune Checkpoint InhibitorsIBA 11/2019
1	IpilimumabIBA 11/2019

Therapy/Procedure

2	Immunotherapy 05/2024 - 10/2021
1	Aftercare (After-Treatment) 11/2019